You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Leukemia, Plasma Cell

Showing 9951 - 9975 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Head and Neck Tumors Trial in Worldwide (biological, drug, radiation)

Active, not recruiting
  • Head and Neck Neoplasms
  • Pembrolizumab
  • +4 more
  • Los Angeles, California
  • +150 more
Dec 7, 2022

Immune Markers in Pediatric ITP

Not yet recruiting
  • ITP - Immune Thrombocytopenia
  • complete blood count, CD3+ , CD4+ , CD8+, CD16+, CD56+, IFN-γ.
  • (no location specified)
Oct 17, 2023

Lymphoma Trial in Worldwide (Glofitamab, Tocilizumab, Doxorubicin)

Recruiting
  • Lymphoma
  • Duarte, California
  • +13 more
Aug 18, 2022

Optimization of Psoriatic and Seronegative Rheumatoid Arthritis

Recruiting
  • Psoriatic Arthritis
  • Rheumatoid Arthritis
  • Phenotyping of synovial immune and stromal cells
  • Rome, Italy
  • +1 more
Mar 2, 2023

Hepatocellular Carcinoma Trial in Jinan (PD-1 plus stereotactic body radiotherapy)

Recruiting
  • Hepatocellular Carcinoma
  • PD-1 plus stereotactic body radiotherapy
  • Jinan, Shandong, China
    Shandong Cancer Hospital and Institute
May 3, 2022

Head and Neck Tumors Trial in Taipei (Afatinib Oral Tablet, Pembrolizumab Injection)

Completed
  • Head and Neck Neoplasms
  • Afatinib Oral Tablet
  • Pembrolizumab Injection
  • Taipei, Taiwan
    National Taiwan University Hospital
Apr 19, 2022

Small-cell Lung Cancer Trial in Atlanta (Proton-beam Therapy for Small Cell Lung Cancer)

Recruiting
  • Small-cell Lung Cancer
  • Proton-beam Therapy for Small Cell Lung Cancer
  • Atlanta, Georgia
    Winship Cancer Institute
Feb 18, 2022

NSCLC Trial in Boston, New York (MPDL3280A, Carboplatin, Nab-paclitaxel)

Completed
  • Carcinoma, Non-Small-Cell Lung
  • Boston, Massachusetts
  • +1 more
Oct 12, 2022

Renal Cell Carcinoma Trial in Houston (Perfusion CT scan)

Active, not recruiting
  • Renal Cell Carcinoma
  • Perfusion CT scan
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Dec 6, 2022

NSCLC Trial in China (Atezolizumab, Placebo, Bevacizumab)

Active, not recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Beijing City, China
  • +22 more
Dec 7, 2022

NSCLC, Neoadjuvant Therapy Trial in Hangzhou (Serplulimab and neoadjuvant therapy, surgical resection of lung cancer)

Recruiting
  • NSCLC
  • Neoadjuvant Therapy
  • Serplulimab and neoadjuvant therapy
  • surgical resection of lung cancer
  • Hangzhou, China
    2nd Affiliated Hospital, School of Medicine, Zhejiang University
May 22, 2023

Collection of Anti-SARS-CoV-2 Immune Plasma

Completed
  • Coronavirus Disease 2019 (COVID-19)
    • Torrance, California
    • +2 more
    Mar 3, 2021

    Head and Neck Squamous Cell Carcinoma, Radiotherapy, Immunotherapy Trial in Wuhan (induction therapy; surgery; radiotherapy)

    Recruiting
    • Head and Neck Squamous Cell Carcinoma
    • +3 more
    • induction therapy; surgery; radiotherapy
    • Wuhan, Hubei, China
      Hubei Cancer Hospital
    Jul 25, 2022

    Carcinoma, NSCLC Trial in Worldwide (nivolumab, ipilimumab, cabozantinib)

    Withdrawn
    • Carcinoma, Non-small Cell Lung Cancer
    • nivolumab
    • +5 more
    • Detroit, Michigan
    • +22 more
    Mar 8, 2022

    Tumors Trial (vibostolimab, pembrolizumab, pemetrexed)

    Active, not recruiting
    • Neoplasms
    • vibostolimab
    • +6 more
    • (no location specified)
    Apr 22, 2022

    Open Angle Glaucoma Trial in Albury, Melbourne (ONL1204 Ophthalmic solution (Dose A), ONL1204 Ophthalmic solution (Dose B), Sham

    Not yet recruiting
    • Open Angle Glaucoma
    • ONL1204 Ophthalmic solution (Dose A)
    • +2 more
    • Albury, New South Wales, Australia
    • +1 more
    Dec 6, 2021

    Non Small Cell Lung Cancer Trial in China (AZD3759)

    Completed
    • Non Small Cell Lung Cancer
    • Guangzhou, Guangdong, China
    • +3 more
    Nov 22, 2022

    HIV-1 Trial (Doravirine, Darunavir, Ritonavir)

    Active, not recruiting
    Has Results
    • HIV-1
    • (no location specified)
    Aug 19, 2022

    Applanation Tonometry in the Diagnosis of Giant Cell Arteritis

    Not yet recruiting
    • Giant Cell Arteritis
    • Applanation tonometry
    • Montreal, Quebec, Canada
      Vasculitis Clinic, Hopital du Sacre-Coeur de Montreal
    Jan 26, 2023

    Atezolizumab Combined With Chemotherapy in Extensive Stage SCLC

    Completed
    • Small Cell Lung Cancer
    • atezolizumab
    • Chalon-sur-Saône, France
    • +1 more
    Jan 5, 2023

    Giant Cell Tumor of Bone Trial (XGEVA®)

    Not yet recruiting
    • Giant Cell Tumor of Bone
    • (no location specified)
    Mar 3, 2022

    Nutritional Requirements Trial in Columbus (Zero hard-boiled egg at 0 h, One hard-boiled egg at 0 h, Two hard-boiled eggs at 0

    Recruiting
    • Nutritional Requirements
    • Zero hard-boiled egg at 0 h
    • +5 more
    • Columbus, Ohio
      Ohio State University
    Dec 16, 2022

    Heart Transplantation Trial in Madrid (Autologous thyTreg)

    Recruiting
    • Heart Transplantation
    • Autologous thyTreg
    • Madrid, Spain
      Hospital General Universitario Gregorio Marañon
    Dec 5, 2022

    Oral Cavity Squamous Cell Carcinoma, Stage I Lip and Oral Cavity Cancer AJCC v8, Stage II Lip and Oral Cavity Cancer AJCC v8

    Not yet recruiting
    • Oral Cavity Squamous Cell Carcinoma
    • +4 more
    • Near Infrared Imaging
    • +2 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Dec 5, 2022

    Oral Squamous Cell Carcinoma, Neoadjvant Therapy, Anti-PD-1 Trial in Shanghai (Toripalimab (anti-programmed death-1 inhibitor),

    Recruiting
    • Oral Squamous Cell Carcinoma
    • +3 more
    • Toripalimab (anti-programmed death-1 inhibitor)
    • +4 more
    • Shanghai, Shanghai, China
      Ninth People's Hospital, Shanghai Jiao Tong University School of
    Oct 8, 2022